MMV invests in partnerships, including those which strengthen research and manufacturing capacity in Africa.

Here are recent key milestones in this area: 

• One pregnancy registry [2] established in Kenya, with permission granted for expansion to Burkina Faso
• Technology transfer resulted in the opening of a testing centre for resistance profiling in Burkina Faso
• MMV has built an extensive network [3]of over 400 partners in 50 countries since its inception in 1999
• B&O Pharma selected as a manufacturing partner for low-dose primaquine for the prevention of relapse P. vivax malaria